Compare Heron Therapeutics Inc (HRTX) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Remitly Global Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Remitly Global Inc trades at $23.74 (market cap $5.02B). The key difference: Remitly Global Inc is far larger — about 54.9× Heron Therapeutics Inc's market cap, and Remitly Global Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | RELY | |
|---|---|---|
Market Cap | $91.46M | $5.02B |
Sector | Health | Technology |
52-Week High | $1.96 | $25.23 |
52-Week Low | $0.39 | $12.20 |
Enterprise Value | $189.36M | $4.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
RELY trades at $23.84, down 1.2% on the day, with a bullish technical signal from moving averages and strong analyst consensus. The company shows accelerating revenue growth, reaching $1.64 billion in 2025, and achieved profitability with net income of $67.93 million. Recent news highlights expansion into the UAE market and positive earnings beats.
The outlook is positive, driven by market share gains in the remittance sector and raised 2026 guidance. Key risks include intense competition and execution challenges in international expansion. Wall Street sentiment is strongly bullish with a $27.40 price target, suggesting 15% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
